Aspirin Use in Older Adults May Alter Cancer Outcomes

Long-term follow-up from the ASPREE trial raises new questions about routine low-dose aspirin use and cancer mortality in seniors.

Extended follow-up of the ASPREE cohort suggests that starting low-dose aspirin in otherwise healthy older adults does not lower overall cancer risk and may be associated with a modest increase in cancer-related mortality, while effects vary by cancer type.

Study Details

Low-dose aspirin has long been studied for cancer prevention, particularly for colore…